N-acetyl-β-hexosaminidase with biochemical and morphological parameters in autoimmune liver diseases

Experimental and Clinical Hepatology

Volumn 3, Issue 1, 2007, Pages 7-13

  Knaś, Małgorzata ^a   Dutkiewicz, Ewa ^b   Borzym Kluczyk, Małgorzata ^a   Stypułkowska, Anna ^a   Zwierz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Holy Cross Academy   (Poland)

Author keywords

Autoimmune hepatitis; N acetyl hexosaminidase HEX; Primary biliary cirrhosis

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; BETA N ACETYLHEXOSAMINIDASE; BETA N ACETYLHEXOSAMINIDASE A; BETA N ACETYLHEXOSAMINIDASE B; BILE ACID; BILIRUBIN; GLYCOCONJUGATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYSOSOME ENZYME;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CHEMICAL ANALYSIS; CHOLESTASIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIVER FIBROSIS; LYSOSOME MEMBRANE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; TISSUE REPAIR; TREATMENT DURATION;

EID: 34547889880     PISSN: 17343038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Sherlock S, Dooley J. Diseases of the liver and biliary tract. Blackwell Science 1997; (10): 239-252.
2. Batts KP, Ludwig J. Histopathology of autoimmune chronic active hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. Raven Press, New York, 1991; 75-92.
3. Desmet VJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1518.
4. Ludwig J. Histopathological diagnosis and terminology of chronic hepatitis. J Hepatol 1995; 23 (49-53).
5. Ishak KBA, Bianchi L. Histological grading and staging of chronic hepatitis. J Hepatology 1995; 22: 696-699.
6. Mackay IR. Molecular aspects of autoimmune liver disease, In: The liver biology and pathobiology. Ed. Arias I. M., Boyer J. L., Fausto N., Jakoby W. B., Schachter D. A., Shafriz D. A. Raven Press 1994.
7. Alvarez F, Berg PA, Bianchi FB. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatology 1999; 31: 929-938.
8. Dutkiewicz E, Knaś M, Stypułkowska A et al. Activity of N-acetyl-beta-hexosaminidase and its isoenzymes in serum of patients with autoimmune hepatitis and primary biliary cirrhosis. Exp Clin Hepatol 2006; 2(3): 7-11.
9. Balan V, La Russo NF. Pierwotna marskość żółciowa oraz pierwotne stwardniajace zapalenie dróg żółciowych (Primary biliary cirrhosis and primary sclerosing cholangitis - in Polish). Ed McNally P. R. Mysteries of hepatology. Medical Press, Gdańsk 1999; 42-54.
10. Pott G, Gerlach U. Diagnostic significance of connective tissue enzymes. Enzyme 1980; 25: 394-406.
11. Hultberg B, Palsson B et al. Beta-hexosaminidase in bile and plasma from patients with cholestasis. Liver 1995; 15: 153-158.
12. Arciuch LP, Lebensztejn DM. The activity of N-acetyl-B-hexosaminidase and its isoenzymes in serum of children with chronic hepatitis. Gastroenter Pol 2003; 10: 223-225.
13. Elsafi ME, Hultberg B et al. Lysosomes and human liver disease: a biochemical and immunohistochemical study of B-hexosaminidase. Eur J Clin Chem Clin Biochem 1994; 32: 669-673.
14. Zwierz K, Gindzieński A et al. The degradation of glycoconjugates in the human gastric mucous membrane. Acta Med Acad Sci Hung 1981; 38: 145-152.
15. Koizumi T, Mitsutani N. N-acetyl-β-glucosaminidase activity in hepatic fibrosis. Lab Invest 1964; 13: 752-756.
16. Reglero A, Carretero MI. Increased serum alpha-L-fucosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients. Chin Chim Acta 1980; 103: 155-158.
17. Ackermann W, Pott G, Voss B. Serum concentration of procollagen III peptide in comparison with the serum activity of N-acetyl-β-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver diseases. Clin Chim Acta 1981; 112: 365-369.
18. Gressner AM, Poebruck P. Predictive values of serum N-acetyl-B-D-glucosaminidase for fibrotic liver disorders-correlation with monoamine oxidase activity. Clin Chim Acta 1982; 124: 315-326.
19. Hartleb M. Interpretacja badań laboratoryjnych w hepatologii (Interpretation of laboratory tests in hepatology - in Polish). Pol. Arch. Med. Wew 2004; 287-289.
20. Mackay IR, Arias IM et al. Molecular aspects of autoimmune liver disease. The liver Biol and Pathobiol 1994; 3: 1267-1285.
21. Czaja AJ. Autoimmunologiczne zapalenie watroby (Autoimmune hepatitis - in Polish). Ed. McNally P. Mysteries of hepatology. Medical Press 1999; 19-41.
22. Hultberg B, Isaksson A, Jansson L. B-hexosaminidase serum from patients with cirrhosis and cholestasis. Enzyme 1981; 26: 296-300.
23. Salloum MS. Przydatność oznaczania N-acetylo-β-heksozoaminidazy i jej izoenzymów w surowicy krwi i moczu w wybranych chorobach watroby u dzieci (the value of N-acetyl-β-hexosaminidase and its isoenzymes determinations in blood serum and urine in selected liver diseases in children - in Polish). Doctoral dissertation, Białystok 1999.
24. Zwierz K, Borzym-Kluczyk M. Badania biochemiczne stosowane w chorobach watroby (Biochemical tests used in liver diseases - in Polish). Ed. J Polański Hepatologia kompendium. Warszawa 2004; 1: 47-49.
25. Friedman LS, Martin P, Munoz SJ. Liver function tests and the objective evaluation of the patient with liver disease. Ed. Zakim D., Boyer T Hepatology: A Textbook of Liver Disease. Philadelphia 1996.
26. Elsafi ME, Hultberg B et al. Immunohistochemical demonstration of Beta-hexosaminidase in cirrhosis and cholestatic human livers with a monoclonal antibody. Liver 1990; 11: 350-354.
27. Shapiro J M, Smith H et al. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20: 137-140.
28. Habior A, Krzeski P, Gugulski A. Primary biliary cirrhosis in Poland. Gastroenterol Pol 1994; 1: 133-137.
29. Krzeski P, Habior A et al. Model przeżycia dla polskiej populacji chorych z pierwotna żółciowa marskościa watroby. (Survival model for Polish population of patients with primary biliary liver cirrhosis - in Polish) Gastroenterol Pol 1998; 5,4: 355-361.
30. Krzeski PZW, Kraszewska E. Is serum bilirubin concentration the only valid prognostic marker in Primary Biliary Cirrhosis. Hepatology 1999; 30: 865-869.
31. Dickson ER and RKMD. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1998; 10: 1-7.
32. Kenneth E, Sherman MD. Wartość diagnostyczna testów watrobowych. (Diagnostic value of liver function tests - in Polish) Ed. McNally P. R. Gdańsk 1999, Medical Press. 1-9.
33. Markowski T, Arciuch LP et al. Laboratory diagnosis of ethyl alcohol dependence syndrome. Post Hig Med Dośw 2001; 55: 113-120.
34. Kryczka W, Zwierz K, Borzym M. N-acetyl-β-hexosaminidase pretreatment levels and interferon alfa-2 response in patients with chronic hepatitis B and C. Med Sci Mon 1999; 5: 116-118.
35. Ratziu V, Giral P, Charlotte F. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117-1123.
36. Boroń-Kaczmarska AMI. Badania w chorobach watroby - wybrane zagadnienia. (Investigations in liver diseases - selected problems - in Polish) Hepatologia 1 2001 (Medical Science Review): 4-8.
37. Ullrich K, Gieselman V et al. Endocytosis of lysosomal enzymes by non-parenchymal rat liver cells. Biochem J 1979; 182: 329-335.
38. Halvorson MR, Campbell JL et al. Comparative evacuation of the clinical utility of three markers of ethanol intake: the effect of gender. Alcohol Chin Exp Res 1993; 17: 225-229.
39. Skudlarek MD, Nowak EK et al. Processing of lysosomal enzymes in macrophages and kidney. In Lysosomes in Biology and Pathology. Amsterdam, Elsevier 1984: 17-44.
40. Hultberg B, Hagerstrand I et al. Source of increased beta-hexosammidade in rat liver cirrhosis. Enzyme 1998; 40: 18-24.
41. Kozłowska J, Łoch T, Nazzal K, Jabłońska J, Cianciara J. Value of serum determination of biochemical markers of fibrosis in patients with liver cirrhosis. Med Sci Monit 1999; 5: 57-61.
42. Gabrielli GB, Capra F, Casaril M. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis. Clin Chim Acta 1996; 252: 171-180.
43. Lebensztejn DM. Ocena biochemiczna i morfologiczna procesu włóknienia watroby u dzieci z przewlekłym zapaleniem watroby typu B (Biochemical and morphological assessment of liver fibrosis process in children with chronic hepatitis B - in Polish). Dissertation for doctor habilitatus degree. Białystok 2002.